Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
life sciences
national
3
×
national blog main
national top stories
new york blog main
amgen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
europe blog main
indiana blog main
indiana top stories
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
accent therapeutics
aducanumab
alder biopharmaceuticals
allergan
alzheimer's disease
amblyotech
What
fda
medicines
3
×
new
3
×
class
migraine
nod
activity
adults
allergan
amgen
approval
approvals
approved
bio
biogen
candidates
clamped
covid
delays
developed
developing
drug
economic
fast
gets
head
including
ipo
isn’t
lot
monday
oric’s
pain
pill
preventive
roundup
showing
spread
starts
testing
Language
unset
Current search:
national
×
new
×
medicines
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
